Royalty Pharma(RPRX)
$68.67-0.01 (-0.01%)
RPRX
Royalty Pharma etf exposure
$68.67
At close:-0.01 (-0.01%)
Want to see RPRX full AI Analyst Report?
ETFs with Royalty Pharma (RPRX) Exposure
1,358 Followers
The following ETFs maintain exposure to Royalty Pharma (RPRX). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
594 ETFs Hold Royalty Pharma (RPRX)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in RPRX |
|---|---|---|---|---|---|---|
| CCGP | Counterpoint Global CIBC Global Permanence ETF Trust Units | $2.20M | ― | 10.12% | $222.94K | <0.01% |
| CCUL | Counterpoint Global CIBC U.S. Large Cap Growth ETF Trust Units | $4.77M | ― | 8.77% | $418.04K | <0.01% |
| RKLC | Rocklinc Principled Equity ETF Trust Units | $45.96M | ― | 7.39% | $2.99M | 0.01% |
| PBE | Invesco Dynamic Biotechnology & Genome ETF | $425.03M | 0.59% | 5.70% | $24.24M | 0.08% |
| CGDV | CI Global Minimum Downside Volatility Index ETF (CAD-Hedged) Trust Units -Hedged- | $26.65M | 0.44% | 5.35% | $13.64M | 0.04% |
| ELCF | Eventide Large Cap Focus ETF | $955.60K | 0.75% | 5.32% | $50.27K | <0.01% |
| PTNT | Corgi IP Licensing & Royalties ETF | $851.51K | 0.35% | 5.01% | $42.69K | <0.01% |
| IHE | iShares U.S. Pharmaceuticals ETF | $1.72B | 0.37% | 4.81% | $81.75M | 0.27% |
| ELCV | Eventide High Dividend ETF | $308.26M | 0.49% | 4.57% | $13.93M | 0.05% |
| ETDG | Eventide Dividend Growth ETF | $8.59M | 0.95% | 4.51% | $381.31K | <0.01% |
| ADPV | Adaptiv Select ETF | $170.81M | 1.00% | 4.11% | $7.02M | 0.02% |
| GFLW | VictoryShares Free Cash Flow Growth ETF | $1.14B | 0.39% | 3.24% | $36.54M | 0.12% |
| SAMM | Strategas Macro Momentum ETF | $41.32M | 0.65% | 2.97% | $1.23M | <0.01% |
| BIOT | L&G Pharma Breakthrough UCITS ETF | $23.97M | 0.49% | 2.80% | $664.96K | <0.01% |
| MVFD | Monarch Volume Factor Dividend Tree ETF | $148.85M | 1.10% | 2.79% | $4.08M | 0.01% |
| OASC | OneAscent Small Cap Core ETF | $98.35M | 0.69% | 2.67% | $2.60M | <0.01% |
| WEBD | Amundi Index MSCI USA SRI PAB -UCITS ETF DR C- Capitalisation | ― | 0.19% | 2.64% | $17.47M | 0.06% |
| USRIH | Amundi Index MSCI USA SRI PAB -UCITS ETF DR Hedged- Capitalisation | $178.98M | 0.21% | 2.64% | $17.47M | 0.06% |
| QMOM | Alpha Architect U.S. Quantitative Momentum ETF | $384.49M | 0.28% | 2.56% | $9.83M | 0.03% |
| XPH | SPDR S&P Pharmaceuticals ETF | $516.57M | 0.35% | 2.31% | $11.92M | 0.04% |
| SMRI | Bushido Capital US Equity ETF | $709.33M | 0.71% | 2.27% | $16.12M | 0.05% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $127.14M | 0.19% | 2.03% | $2.57M | <0.01% |
| AUSF | Global X Adaptive U.S. Factor ETF | $891.77M | 0.27% | 2.03% | $18.08M | 0.06% |
| FFTY | Innovator IBD 50 ETF | $50.73M | 0.80% | 2.01% | $1.02M | <0.01% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $76.09M | 0.37% | 2.01% | $28.03M | 0.09% |
| TSME | Thrivent Small-Mid Cap ESG ETF | $818.28M | 0.65% | 2.00% | $16.36M | 0.05% |
| VFLO | VictoryShares Free Cash Flow ETF | $12.76B | 0.39% | 1.98% | $247.83M | 0.81% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | $20.42M | 0.75% | 1.89% | $383.51K | <0.01% |
| UPSD | Aptus Large Cap Upside ETF | $143.61M | 0.79% | 1.86% | $2.67M | <0.01% |
| CZA | Invesco Zacks Mid-Cap ETF | $181.58M | 0.69% | 1.85% | $3.30M | 0.01% |
| FCPI | Fidelity Stocks for Inflation ETF | $273.17M | 0.15% | 1.73% | $4.72M | 0.02% |
| QQQJ | Invesco NASDAQ Next Gen 100 ETF | $1.13B | 0.15% | 1.63% | $18.25M | 0.06% |
| EQQJ | Invesco NASDAQ Next Generation 100 UCITS ETF AccumGBP | $46.49M | 0.25% | 1.62% | $772.04K | <0.01% |
| FPX | First Trust US Equity Opportunities ETF | $1.31B | 0.57% | 1.59% | $20.64M | 0.07% |
| FTG2 | First Trust US Equity Opportunities UCITS ETF | $13.70M | 0.70% | 1.59% | $215.86K | <0.01% |
| INFBN | Horizon Kinetics ICAV - Inflation Beneficiaries UCITS ETF | ― | 0.86% | 1.56% | $1.21M | <0.01% |
| INFEA | Horizon Kinetics Full-Cycle Inflation Equity Fund UCITS ETF Accum Shs EUR | ― | 0.85% | 1.56% | $1.21M | <0.01% |
| INFL | Horizon Kinetics Inflation Beneficiaries ETF | $1.52B | 0.85% | 1.50% | $22.85M | 0.07% |
| EHLS | Even Herd Long Short ETF | $53.84M | 3.35% | 1.47% | $789.96K | <0.01% |
| VFMV | Vanguard U.S. Minimum Volatility ETF | $518.81M | 0.13% | 1.46% | $7.57M | 0.02% |
| CGDG | Capital Group Dividend Growers ETF | $6.00B | 0.47% | 1.37% | $81.94M | 0.27% |
| ZLSU | BMO Long Short US Equity ETF | $226.64M | 0.76% | 1.36% | $3.10M | <0.01% |
| LSEQ | Harbor Long-Short Equity ETF | $16.69M | 2.28% | 1.35% | $224.58K | <0.01% |
| CVY | Invesco Zacks Multi-Asset Income ETF | $117.75M | 1.15% | 1.19% | $1.39M | <0.01% |
| WSRI | Wealthsimple North America Socially Responsible Index ETF | $1.07B | 0.23% | 1.19% | $12.75M | 0.03% |
| NYNY | Corgi NYC Based ETF | $818.50K | 0.20% | 1.19% | $9,730.55 | <0.01% |
| HELX | Franklin Genomic Advancements ETF | $32.94M | 0.50% | 1.18% | $386.46K | <0.01% |
| ZHU | BMO Equal Weight US Health Care Index ETF | $20.62M | 0.40% | 1.12% | $163.46K | <0.01% |
| ZUH | BMO EqWgt US Health | $195.73M | 0.40% | 1.10% | $2.15M | <0.01% |
| TULV | TD Q U.S. Low Volatility ETF | $57.82M | 0.35% | 1.04% | $590.97K | <0.01% |
| BOUT | Innovator IBD Breakout Opportunities ETF | $13.62M | 0.80% | 1.01% | $137.19K | <0.01% |
| AESR | Anfield U.S. Equity Sector Rotation ETF | $239.65M | 0.97% | 0.99% | $2.36M | <0.01% |
| PID | Invesco International Dividend Achievers ETF | $881.39M | 0.53% | 0.98% | $8.48M | 0.03% |
| AEMV | Harbor AlphaEdge Mid Cap Value ETF | $2.50M | 0.38% | 0.98% | $24.04K | <0.01% |
| FLQM | Franklin LibertyQ U.S. Mid Cap Equity ETF | $1.47B | 0.30% | 0.97% | $14.00M | 0.05% |
| JSEU | JPMorgan ETFs (IE) ICAV - US Res En Index Eq SRI Par Al | $490.46M | 0.22% | 0.96% | $5.75M | 0.02% |
| JSHE | JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity SRI Paris Aligned UCITS ETF AccumHedged EUR | $69.88M | 0.22% | 0.96% | $5.75M | 0.02% |
| JSHC | JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity SRI Paris Aligned UCITS ETF AccumHedged CHF | $12.86M | 0.20% | 0.96% | $5.75M | 0.02% |
| JSUD | JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity SRI Paris Aligned UCITS ETF Unhedged USD | $2.64M | 0.20% | 0.96% | $5.75M | 0.02% |
| JSUG | JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity SRI Paris Aligned Active UCITS ETF Hedged GBP | $931.46K | 0.20% | 0.96% | $5.75M | 0.02% |
| ESLV | Eventide Large Cap Value ETF | $18.77M | 0.39% | 0.92% | $170.67K | <0.01% |
| LGLV | SPDR SSGA US Large Cap Low Volatility Index ETF | $1.25B | 0.12% | 0.89% | $11.03M | 0.04% |
| PAUS | Invesco MSCI USA ESG Climate Paris Aligned UCITS ETF AccumUSD | $59.48M | 0.09% | 0.88% | $514.96K | <0.01% |
| FLRG | Fidelity U.S. Multifactor ETF | $284.77M | 0.15% | 0.88% | $2.50M | <0.01% |
| ZSRM | MSCI USA SRI S-Series PAB 5% Capped UCITS ETF EUR Capitalisation | $87.90M | 0.26% | 0.87% | $3.08M | <0.01% |
| EKLD | MSCI USA SRI S-Series PAB 5% Capped UCITS ETF Capitalisation | $100.91M | 0.26% | 0.87% | $3.08M | <0.01% |
| EKUS | MSCI USA SRI S-Series PAB 5% Capped UCITS ETF EUR Distribution | $64.42M | 0.26% | 0.87% | $3.08M | <0.01% |
| ESUM | Eventide US Market ETF | $193.69M | 0.39% | 0.87% | $1.65M | <0.01% |
| PABU | iShares Paris-Aligned Climate MSCI USA ETF | $2.42B | 0.10% | 0.85% | $20.29M | 0.07% |
| NUDV | Nuveen ESG Dividend ETF | $56.82M | 0.26% | 0.85% | $474.44K | <0.01% |
| NULV | Nuveen ESG Large-Cap Value ETF | $2.59B | 0.26% | 0.84% | $21.51M | 0.07% |
| DVVY | Invesco Diversified Dividend Opportunities ETF | $2.77M | 0.33% | 0.81% | $22.11K | <0.01% |
| FFF | Founders 100 ETF | $5.97M | 0.75% | 0.81% | $48.24K | <0.01% |
| RKSG | Ruk Strategic Growth ETF | $2.82M | 0.50% | 0.80% | $22.61K | <0.01% |
| TNXT | T. Rowe Price Innovation Leaders ETF | $18.12M | 0.49% | 0.80% | $145.14K | <0.01% |
| ABFL | FCF US Quality ETF | $442.00M | 0.49% | 0.80% | $3.53M | 0.01% |
| WGES | Lyxor MSCI World ESG Leaders Extra (DR) UCITS ETF Distribution -Dist- | $80.19M | 0.19% | 0.77% | $34.13M | 0.11% |
| WSRI | Amundi Index MSCI World SRI PAB -UCITS ETF DR C- Capitalisation | $3.70B | 0.19% | 0.77% | $34.13M | 0.11% |
| MWSH | Amundi Index MSCI World SRI PAB -UCITS ETF DR Hedged- Capitalisation | $227.62M | 0.21% | 0.77% | $34.13M | 0.11% |
| UC95 | UBS Low Volat Ptg.Shs Class -A- USD | $67.87M | 0.18% | 0.76% | $546.59K | <0.01% |
| UBUV | UBS (Irl) ETF Plc - Factor MSCI USA Low Volatility UCITS ETF (hedged to EUR) A-acc | $4.17M | 0.21% | 0.76% | $546.59K | <0.01% |
| SMOT | VanEck Morningstar US SMID Moat UCITS ETF Accum A USD | $13.80M | 0.56% | 0.75% | $103.06K | <0.01% |
| SMOT | VanEck Morningstar SMID Moat ETF | $290.62M | 0.49% | 0.75% | $2.17M | <0.01% |
| FUSD | Fide US Qlty In Shs USD | $1.47B | 0.25% | 0.74% | $15.18M | 0.05% |
| FUSA | Fide US Qlty In Accum Shs USD | $439.63M | 0.25% | 0.74% | $15.18M | 0.05% |
| FEUH | Fidelity US Quality Income UCITS ETF Accum Hedged GBP | $6.50M | 0.30% | 0.74% | $15.18M | 0.05% |
| FUSU | Fidelity US Quality Income UCITS ETF Accum Shs Hedged EUR | $133.95M | 0.30% | 0.74% | $15.18M | 0.05% |
| BOSS | ― | ― | ― | 0.74% | $47.85K | <0.01% |
| KU70 | HSBC MSCI USA Climate Paris Aligned UCITS ETF USD | $338.33K | 0.18% | 0.73% | $254.78K | <0.01% |
| AIUU | AXA IM MSCI USA Equity PAB UCITS ETF Accum USD | $47.63M | 0.17% | 0.73% | $347.42K | <0.01% |
| AW16 | UBS (Irl) ETF plc - MSCI USA Climate Paris Aligned UCITS ETF Accum A USD | $144.78M | 0.09% | 0.72% | $1.06M | <0.01% |
| QQJG | ― | ― | ― | 0.69% | $52.41K | <0.01% |
| FTHI | First Trust BuyWrite Income ETF | $2.53B | 0.75% | 0.68% | $17.00M | 0.06% |
| PAWD | Invesco MSCI World ESG Climate Paris Aligned UCITS ETF AccumUSD | $29.59M | 0.21% | 0.65% | $189.69K | <0.01% |
| PABW | Amundi MSCI World Climate Paris Aligned PAB UCITS ETF DR (C) | $1.45B | 0.24% | 0.64% | $9.29M | 0.03% |
| EMWE | MSCI World SRI S-Series PAB 5% Capped UCITS ETF EUR Capitalisation | $953.37M | 0.27% | 0.62% | $10.33M | 0.03% |
| EWRD | MSCI World SRI S-Series PAB 5% Capped UCITS ETF Capitalisation | $56.93M | 0.27% | 0.62% | $10.33M | 0.03% |
| EMWD | Lumyna Funds - US Debt - Securitised Fund | $110.64M | 0.27% | 0.62% | $10.33M | 0.03% |
| AWDU | AXA IM MSCI World Equity PAB UCITS ETF | $1.59B | 0.40% | 0.61% | $11.36M | 0.04% |
| AWDE | AXA IM MSCI World Equity PAB UCITS ETF Accum-(H)- EUR | $237.33M | 0.43% | 0.61% | $11.36M | 0.04% |

Popular ETF Comparisons
RPRX ETF Exposure FAQ
What ETFs hold Royalty Pharma stock?
Royalty Pharma (RPRX) is currently held by 594 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to RPRX include iShares (IHE), Invesco (PBE) and Eventide (ELCV).
Which ETF has the largest exposure to RPRX?
The ETF with the largest exposure to RPRX is iShares (IHE), with approximately $81.75M in market value exposure.
How much RPRX stock is held by ETFs?
ETFs currently hold approximately $137.67M worth of Royalty Pharma (RPRX) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.

